Alzheimer's disease: Review of hormone therapy trials and implications for treatment and prevention after menopause

Journal of Steroid Biochemistry and Molecular Biology

Volumn 142, Issue , 2014, Pages 99-106

  Henderson, Victor W ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Estrogen; Hormone therapy; Menopause; Selective estrogen receptor modulator

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; PHYTOESTROGEN;

ALZHEIMER DISEASE; CHEMOPROPHYLAXIS; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; ESTROGEN THERAPY; HORMONAL THERAPY; HUMAN; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; MENOPAUSE; NONHUMAN; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR;

ALZHEIMER'S DISEASE; ESTROGEN; HORMONE THERAPY; MENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

AGED; ALZHEIMER DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 84899948662     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.05.010     Document Type: Review

References (106)

1. H.L. Judd, and N. Fournet Changes of ovarian hormonal function with aging Experimental Gerontology 29 1994 285 298
2. H.G. Burger, E.C. Dudley, J. Cui, L. Dennerstein, and J.L. Hopper A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition Journal of Clinical Endocrinology and Metabolism 85 2000 2832 2838
3. R.S. Vest, and C.J. Pike Gender, sex steroid hormones, and Alzheimer's disease Hormones and Behavior 63 2013 301 307
4. P.J. Shughrue, P.J. Scrimo, and I. Merchenthaler Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain Neuroscience 96 2000 41 49
5. P.J. Shughrue, M.V. Lane, and I. Merchenthaler Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system Journal of Comparative Neurology 388 1997 507 525
6. L. Raz, M.M. Khan, V.B. Mahesh, R.K. Vadlamudi, and D.W. Brann Rapid estrogen signaling in the brain Neuro-Signals 16 2008 140 153
7. E.R. Prossnitz, and M. Maggiolini Mechanisms of estrogen signaling and gene expression via GPR30 Molecular and Cellular Endocrinology 308 2009 32 38
8. M. Umetani, H. Domoto, A.K. Gormley, I.S. Yuhanna, C.L. Cummins, N.B. Javitt, K.S. Korach, P.W. Shaul, and D.J. Mangelsdorf 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen Nature Medicine 13 2007 1185 1192
9. S. Pozzi, V. Benedusi, A. Maggi, and E. Vegeto Estrogen action in neuroprotection and brain inflammation Annals of the New York Academy of Sciences 1089 2006 302 323
10. C. Reitz, C. Brayne, and R. Mayeux Epidemiology of Alzheimer disease Nature Reviews Neurology 7 2011 137 152
11. B.J. Small, L. Fratiglioni, M. Viitanen, B. Winblad, and L. Bäckman The course of cognitive impairment in preclinical Alzheimer disease Archives of Neurology 57 2000 839 844
12. V.W. Henderson, and J.G. Buckwalter Cognitive deficits of men and women with Alzheimer's disease Neurology 44 1994 90 96
13. D.N. Ripich, S.A. Petrill, P.J. Whitehouse, and E.W. Ziol Gender differences in language of AD patients: a longitudinal study Neurology 45 1995 299 302
14. J. Götz, F. Chen, J. van Dorpe, and R.M. Nitsch Formation of neurofibrillary tangles in P301L tau transgenic mice induced by A42 fibrils Science 293 2001 1491 1495
15. L.J. Launer, K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci, C. Brayne, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, A. Lobo, J.M. Martinez-Lage, T. Stijnen, and A. Hofman Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses Neurology 52 1999 78 84
16. W.A. Kukull, R. Higdon, J.D. Bowen, W.C. McCormick, L. Teri, G.D. Schellenberg, G. van Belle, L. Jolley, E.B. Larson, and Dementia Alzheimer disease incidence: a prospective cohort study Archives of Neurology 59 2002 1737 1746
17. L.A. Farrer, L.A. Cupples, J.L. Haines, B. Hyman, W.A. Kukull, R. Mayeux, R.H. Myers, M.A. Pericak-Vance, N. Risch, and C.M. van Duijn Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease Journal of the American Medical Association 278 1997 1349 1356
18. P.M. Bretsky, J.G. Buckwalter, T.E. Seeman, C.A. Miller, J. Poirier, G.D. Schellenberg, C.E. Finch, and V.W. Henderson Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease Alzheimer Disease and Associated Disorders 13 1999 216 221
19. D.J. Stone, I. Rozovsky, T.E. Morgan, C.P. Anderson, H. Hajian, and C.E. Finch Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro Experimental Neurology 143 1997 313 318
20. V. Leduc, D. Domenger, L. De Beaumont, D. Lalonde, S. Bélanger-Jasmin, and J. Poirier Function and comorbidities of apolipoprotein E in Alzheimer's disease International Journal of Alzheimer's Disease 2011 10.4061/2011/974361
21. J. Näslund, J. Thyberg, L.O. Tjernberg, C. Wernstedt, A.R. Karlström, N. Bogdanovic, S.E. Gandy, L. Lannfelt, L. Terenius, and C. Nordstedt Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain Neuron 15 1995 219 228
22. K.H. Gylys, J.A. Fein, A.M. Tan, and G.M. Cole Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals Journal of Neurochemistry 84 2003 1442 1451
23. T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinistö, P. Halonen, and K. Kontula Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein New England Journal of Medicine 333 1995 1242 1247
24. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiological Reviews 81 2001 741 746
25. J.T. Coyle, D.L. Price, and M.R. DeLong Alzheimer's disease: a disorder of cortical cholinergic innervation Science 219 1983 1184 1190
26. R.J. Bateman, C. Xiong, T.L. Benzinger, A.M. Fagan, A. Goate, N.C. Fox, D.S. Marcus, N.J. Cairns, X. Xie, T.M. Blazey, D.M. Holtzman, A. Santacruz, V. Buckles, A. Oliver, K. Moulder, P.S. Aisen, B. Ghetti, W.E. Klunk, E. McDade, R.N. Martins, C.L. Masters, R. Mayeux, J.M. Ringman, M.N. Rossor, P.R. Schofield, R.A. Sperling, S. Salloway, and J.C. Morris Dominantly Inherited Alzheimer Network, clinical and biomarker changes in dominantly inherited Alzheimer's disease New England Journal of Medicine 367 2012 795 804
27. J.A. Schneider, Z. Arvanitakis, W. Bang, and D.A. Bennett Mixed brain pathologies account for most dementia cases in community-dwelling older persons Neurology 69 2007 2197 2204
28. X. Yue, M. Lu, T. Lancaster, P. Cao, S. Honda, M. Staufenbiel, N. Harada, Z. Zhong, Y. Shen, and R. Li Brain estrogen deficiency accelerates A(beta) plaque formation in an Alzheimer's disease animal model Proceedings of the National Academy of Sciences of the United States of America 102 2005 19198 19203
29. M. Alvarez-De-La-Rosa, I. Silva, J. Nilsen, M.M. Perez, L.M. Garcia-Segura, J. Avila, and F. Naftolin Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease Annals of the New York Academy of Sciences 1052 2005 210 224
30. C.K. Barha, and L.A. Galea Influence of different estrogens on neuroplasticity and cognition in the hippocampus Biochimica et Biophysica Acta 1800 2010 1056 1067
31. M.R. Foy, M. Baudry, R. Diaz Brinton, and R.F. Thompson Estrogen and hippocampal plasticity in rodent models Journal of Alzheimer's Disease 15 2008 589 603
32. D.B. Dubal, H. Zhu, J. Yu, S.W. Rau, P. Shughrue, I. Merchenthaler, M.S. Kindy, and P.M. Wise Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury Proceedings of the National Academy of Sciences of the United States of America 98 2001 1952 1957
33. Y. Goodman, A.J. Bruce, B. Cheng, and M.P. Mattson Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons Journal of Neurochemistry 66 1996 1836 1844
34. L expression and β-amyloid-induced apoptosis: relevance to Alzheimer's disease Journal of Neurochemistry 72 1999 1552 1563
35. C.D. Toran-Allerand Organotypic culture of the developing cerebral cortex and hypothalamus: relevance to sexual differentiation Psychoneuroendocrinology 16 1991 7 24
36. J.H. Morrison, and M.G. Baxter The ageing cortical synapse: hallmarks and implications for cognitive decline Nature Reviews Neuroscience 13 2012 240 250
37. J. Nilsen, R.W. Irwin, T.K. Gallaher, and R.D. Brinton Estradiol in vivo regulation of brain mitochondrial proteome Journal of Neuroscience 27 2007 14069 14077
38. V.W. Henderson, A. Paganini-Hill, C.K. Emanuel, M.E. Dunn, and J.G. Buckwalter Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects Archives of Neurology 51 1994 896 900
39. V.W. Henderson, L. Watt, and J.G. Buckwalter Cognitive skills associated with estrogen replacement in women with Alzheimer's disease Psychoneuroendocrinology 21 1996 421 430
40. P.M. Doraiswamy, F. Bieber, L. Kaiser, K.R. Krishnan, J. Reuning-Scherer, and B. Gulanski The Alzheimer's disease assessment scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials Neurology 48 1997 1511 1517
41. L.S. Schneider, M.R. Farlow, V.W. Henderson, and J.M. Pogoda Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease Neurology 46 1996 1580 1584
42. H. Fillit, H. Weinreb, I. Cholst, V. Luine, B. McEwen, R. Amador, and J. Zabriskie Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type Psychoneuroendocrinology 11 1986 337 345
43. H. Honjo, Y. Ogino, K. Naitoh, M. Urabe, J. Kitawaki, J. Yasuda, T. Yamamoto, S. Ishihara, H. Okada, T. Yonezawa, K. Hayashi, and T. Nambara In vivo effects by estrone sulfate on the central nervous system - senile dementia (Alzheimer's type) Journal of Steroid Biochemistry 34 1989 521 525
44. T. Ohkura, K. Isse, K. Akazawa, M. Hamamoto, Y. Yaoi, and N. Hagino Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type Endocrine Journal 41 1994 361 371
45. S. Asthana, S. Craft, L.D. Baker, M.A. Raskind, R.S. Birnbaum, C.P. Lofgreen, R.C. Veith, and S.R. Plymate Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study Psychoneuroendocrinology 24 1999 657 677
46. S. Asthana, L.D. Baker, S. Craft, F.Z. Stanczyk, R.C. Veith, M.A. Raskind, and S.R. Plymate High-dose estradiol improves cognition for women with AD: results of a randomized study Neurology 57 2001 605 612
47. W. Wharton, L.D. Baker, C.E. Gleason, M. Dowling, J.H. Barnet, S. Johnson, C. Carlsson, S. Craft, and S. Asthana Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial Journal of Alzheimer's Disease 26 2011 495 505
48. R.A. Mulnard, C.W. Cotman, C. Kawas, C.H. van Dyck, M. Sano, R. Doody, E. Koss, E. Pfeiffer, S. Jin, A. Gamst, M. Grundman, R. Thomas, and L.J. Thal Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial Journal of the American Medical Association 283 2000 1007 1015
49. A.S. Rigaud, G. Andre, B. Vellas, J. Touchon, and J.J. Pere No additional benefit of HRT on response to rivastigmine in menopausal women with AD Neurology 60 2003 148 149
50. V.W. Henderson, A. Paganini-Hill, B.L. Miller, R.J. Elble, P.F. Reyes, D. Shoupe, C.A. McCleary, R.A. Klein, A.M. Hake, and M.R. Farlow Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial Neurology 54 2000 295 301
51. P.N. Wang, S.Q. Liao, R.S. Liu, C.Y. Liu, H.T. Chao, S.R. Lu, H.Y. Yu, S.J. Wang, and H.C. Liu Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study Neurology 54 2000 2061 2066
52. Y.X. Zhang, G. Luo, Z.J. Guo, R.Y. Cui, L.Q. Wang, and C.L. Zhou Quantitative evaluation of the interventional effect of estrogen on Alzheimer's disease Chinese Journal of Clinical Rehabilitation 10 2006 37 39
53. A. Valen-Sendstad, K. Engedal, B. Stray-Pedersen, C. Strobel, L. Barnett, N. Meyer, and M. Nurminemi Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone American Journal of Geriatric Psychiatry 18 2010 11 20
54. B.M. Caldwell, and R.I. Watson An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months Journal of Gerontology 7 1952 228 244
55. H. Honjo, Y. Ogino, K. Tanaka, M. Urabe, T. Kashiwagi, S. Ishihara, H. Okada, K. Araki, S. Fushiki, K. Nakajima, K. Hayashi, M. Hayashi, and T. Sakaki An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled double blind study Journal of the Japan Menopause Society 1 1993 167 171
56. S.J. Birge The role of estrogen in the treatment of Alzheimer's disease Neurology 48 Suppl. 7 1997 S36 S41
57. E. Hogervorst, K. Yaffe, M. Richards, and F.A. Huppert Hormone replacement therapy to maintain cognitive function in women with dementia Cochrane Database of Systemic Reviews 1 2009 CD003799
58. J. Yao, and R.D. Brinton Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease Advances in Pharmacology 64 2012 327 371
59. V.W. Henderson, E.C. Dudley, J.R. Guthrie, H.G. Burger, and L. Dennerstein Estrogen exposures and memory at midlife: a population-based study of women Neurology 60 2003 1369 1371
60. G.A. Greendale, M.-H. Huang, R.G. Wight, T. Seeman, C. Luetters, N.E. Avis, J. Johnston, and A.S. Karlamangla Effects of the menopause transition and hormone use on cognitive performance in midlife women Neurology 72 2009 1850 1857
61. M.T. Weber, M. Mapstone, J. Staskiewicz, and P.M. Maki Reconciling subjective memory complaints with objective memory performance in the menopausal transition Menopause 19 2012 735 741
62. S.D. Edland, W.A. Rocca, R.C. Petersen, R.H. Cha, and E. Kokmen Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn Archives of Neurology 59 2002 1589 1593
63. A. Ott, M.M. Breteler, F. van Harskamp, T. Stijnen, and A. Hofman Incidence and risk of dementia: the Rotterdam study American Journal of Epidemiology 147 1998 574 580
64. A. Paganini-Hill, and V.W. Henderson Estrogen replacement therapy and risk of Alzheimer's disease Archives of Internal Medicine 156 1996 2213 2217
65. M.-X. Tang, D. Jacobs, Y. Stern, K. Marder, P. Schofield, B. Gurland, H. Andrews, and R. Mayeux Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 1996 429 432
66. M. Baldereschi, A. Di Carlo, V. Lepore, L. Bracco, S. Maggi, F. Grigoletto, G. Scarlato, and L. Amaducci Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging Neurology 50 1998 996 1002
67. R.O. Roberts, R.H. Cha, D.S. Knopman, R.C. Petersen, and W.A. Rocca Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings Alzheimer Disease and Associated Disorders 20 2006 141 146
68. W.A. Rocca, J.H. Bower, J.E. Ahlskog, B.R. Grossardt, M. de Andrade, and L.J. Melton III Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause Neurology 69 2007 1074 1083
69. T.K. Phung, B.L. Waltoft, T.M. Laursen, A. Settnes, L.V. Kessing, P.B. Mortensen, and G. Waldemar Hysterectomy, oophorectomy and risk of dementia: a nationwide historical cohort study Dementia and Geriatric Cognitive Disorders 30 2010 43 50
70. D. Kritz-Silverstein, and E. Barrett-Connor Hysterectomy, oophorectomy, and cognitive function in older women Journal of the American Geriatrics Society 50 2002 55 61
71. H.S. Kok, D. Kuh, R. Cooper, Y.T. van der Schouw, D.E. Grobbee, W.M. E, and M. Richards Cognitive function across the life course and the menopausal transition in a British birth cohort Menopause 13 2006 19 27
72. V.W. Henderson, and B.B. Sherwin Surgical versus natural menopause: cognitive issues Menopause 14 2007 572 579
73. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, J.K. Ockene, S.L. Hendrix, B.N. Jones, A.R. Assaf III, R.D. Jackson, J.M. Morley Kotchen, S. Wassertheil-Smoller, J. Wactawski-Wende, and WHIMS Investigators Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study (WHIMS) Journal of the American Medical Association 289 2003 2651 2662
74. S.A. Shumaker, C. Legault, L. Kuller, S.R. Rapp, L. Thal, D.S. Lane, H. Fillit, M.L. Stefanick, S.L. Hendrix, C.E. Lewis, K. Masaki, L.H. Coker, and for the Women's Health Initiative Memory Study Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study Journal of the American Medical Association 291 2004 2947 2958
75. K. Yaffe, K. Krueger, S.R. Cummings, T. Blackwell, V.W. Henderson, S. Sarkar, K. Ensrud, and D. Grady Effect of raloxifene on the prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial American Journal of Psychiatry 162 2005 683 690
76. E. Hogervorst, J. Williams, M. Budge, W. Riedel, and J. Jolles The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis Neuroscience 101 2000 485 512
77. E.S. LeBlanc, J. Janowsky, B.K.S. Chan, and H.D. Nelson Hormone replacement therapy and cognition: systematic review and meta-analysis Journal of the American Medical Association 285 2001 1489 1499
78. D.E. Brenner, W.A. Kukull, A. Stergachis, G. van Belle, J.D. Bowen, W.C. McCormick, L. Teri, and E.B. Larson Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study American Journal of Epidemiology 140 1994 262 267
79. S.C. Waring, W.A. Rocca, R.C. Petersen, P.C. O'Brien, E.G. Tangalos, and E. Kokmen Postmenopausal estrogen replacement therapy and risk of AD: a population-based study Neurology 52 1999 965 970
80. C. Kawas, S. Resnick, A. Morrison, R. Brookmeyer, M. Corrada, A. Zonderman, C. Bacal, D. Donnell Lingle, and E. Metter A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging Neurology 48 1997 1517 1521
81. S. Seshadri, G.L. Zomberg, L.E. Derby, M.W. Myers, H. Jick, and D.A. Drachman Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease Archives of Neurology 58 2001 435 440
82. V.W. Henderson, M.A. Espeland, P.E. Hogan, S.R. Rapp, M.L. Stefanick, J. Wactawski-Wende, K.C. Johnson, S. Wassertheil-Smoller, R. Freeman, and D. Curb Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study [abstract] Neurology 68 Suppl. 1 2007 A205
83. H. Shao, J.C.S. Breitner, R.A. Whitmer, J. Wang, K. Hayden, H. Wengreen, C. Corcoran, J. Tschanz, M. Norton, R. Munger, K. Welsh-Bohmer, P.P. Zandi, and the Cache County Investigators Hormone therapy and AD dementia: new findings from the Cache County study Neurology 79 2012 1846 1852
84. V.W. Henderson Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research Neuroscience 138 2006 1031 1039
85. R.B. Gibbs Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats Neurobiology of Aging 21 2000 107 116
86. S.M. Resnick, and P.M. Maki Effects of hormone replacement therapy on cognitive and brain aging Annals of the New York Academy of Sciences 949 2001 303 314
87. S.M. Resnick, and V.W. Henderson Hormone therapy and risk of Alzheimer disease: a critical time Journal of the American Medical Association 288 2002 2170 2172
88. Y.Z. Bagger, L.B. Tankó, P. Alexandersen, G. Qin, and C. Christiansen Early postmenopausal hormone replacement therapy may prevent cognitive impairment later in life Menopause 12 2005 12 17
89. V.W. Henderson, K.S. Benke, R.C. Green, L.A. Cupples, and L.A. Farrer Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age Journal of Neurology, Neurosurgery and Psychiatry 76 2005 103 105
90. R.A. Whitmer, C.P. Quesenberry, J. Zhou, and K. Yaffe Timing of hormone therapy and dementia: the critical window theory revisited Annals of Neurology 69 2011 163 169
91. G.G. Kuiper, J.G. Lemmen, B. Carlsson, J.C. Corton, S.H. Safe, P.T. van der Saag, B. van der Burg, and J.-A. Gustafsson Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 139 1998 4252 4263
92. V.W. Henderson, J.A. St John, H.N. Hodis, N. Kono, C.A. McCleary, A.A. Franke, W.J. Mack, and WISH Research Group Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial Neurology 78 2012 1841 1848
93. L.R. White, H. Petrovitch, G.W. Ross, K. Masaki, J. Hardman, J. Nelson, D. Davis, and W. Markesbery Brain aging and midlife tofu consumption Journal of the American College of Nutrition 19 2000 242 255
94. J. Nilsen, and R.D. Brinton Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling Proceedings of the National Academy of Sciences of the United States of America 100 2003 10506 10511
95. S. Chen, J. Nilsen, and R.D. Brinton Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications Endocrinology 147 2006 5303 5313
96. D.T. Ohm, E.B. Bloss, W.G. Janssen, K.C. Dietz, S. Wadsworth, W. Lou, N.A. Gee, B.L. Lasley, P.R. Rapp, and J.H. Morrison Clinically relevant hormone treatments fail to induce spinogenesis in prefrontal cortex of aged female rhesus monkeys Journal of Neuroscience 32 2012 11700 11705
97. F.Z. Stanczyk, J.P. Hapgood, S. Winer, and D.R. Mishell Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects Endocrine Reviews 34 2013 171 208
98. A. Sherwood, J.K. Bower, J. McFetridge-Durdle, J.A. Blumenthal, L.K. Newby, and A.L. Hinderliter Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women Arteriosclerosis, Thrombosis, and Vascular Biology 27 2007 1782 1787
99. R. Karim, H.N. Hodis, F.Z. Stanczyk, R.A. Lobo, and W.J. Mack Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women Journal of Clinical Endocrinology and Metabolism 93 2008 131 138
100. H.N. Hodis, W.J. Mack, R.A. Lobo, D. Shoupe, A. Sevanian, P.R. Mahrer, R.H. Selzer, C.C.R. Liu, C.H. Liu Ch, and S.P. Azen Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 135 2001 939 953
101. T.B. Clarkson Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression Menopause 14 2007 373 384
102. J.E. Rossouw, R.L. Prentice, J.E. Manson, L. Wu, D. Barad, V.M. Barnabei, M. Ko, A.Z. LaCroix, K.L. Margolis, and M.L. Stefanick Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause Journal of the American Medical Association 297 2007 1465 1477
103. L.L. Schierbeck, L. Rejnmark, C.L. Tofteng, L. Stilgren, P. Eiken, L. Mosekilde, L. Køber, and J.E. Jensen Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial British Medical Journal 345 2012 e6409
104. S. Asthana, R.D. Brinton, V.W. Henderson, B.S. McEwen, J.H. Morrison, P.J. Schmidt, and Frontiers Proposal for Estrogen and Cognitive Aging Work Groups Frontiers proposal. National Institute of Aging "bench to bedside: estrogen as a case study" Age (Dordrecht, Netherlands) 31 2009 199 210
105. A. Paganini-Hill, and V.W. Henderson Estrogen deficiency and risk of Alzheimer's disease in women American Journal of Epidemiology 140 1994 256 261
106. P.P. Zandi, M.C. Carlson, B.L. Plassman, K.A. Welsh-Bohmer, L.S. Mayer, D.C. Steffens, and J.C.S. Breitner Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County study Journal of the American Medical Association 288 2002 2123 2129